| Date Checked | 2025-12-21 23:42:09 |
|---|---|
| Graham Number | (PB)9.23 vs (PE)9.68 |
| Over / Under Value Percentage | -43.44% vs -48.28% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | CVAC |
| AssetType | Common Stock |
| Name | CureVac NV |
| Description | CureVac NV (CVAC) is a pioneering clinical-stage biopharmaceutical company headquartered in Tübingen, Germany, specializing in advanced messenger RNA (mRNA) technology. The firm is actively developing a robust pipeline of mRNA-based vaccines and therapeutics to address significant unmet medical needs in infectious diseases and oncology. Leveraging its strong scientific expertise and strategic alliances, CureVac is positioned to become a leader in the evolving mRNA landscape, with the potential to revolutionize healthcare solutions both in Europe and globally. |
| CIK | 1809122 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | FRIEDRICH-MIESCHER-STRASSE 15, TÜBINGEN, GERMANY, 72076 |
| OfficialSite | https://www.curevac.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 936719000 |
| EBITDA | 193694000 |
| PERatio | 6.21 |
| PEGRatio | None |
| BookValue | 5.65 |
| DividendPerShare | None |
| EPS | 0.67 |
| RevenuePerShareTTM | 0.44 |
| ProfitMargin | 1.821 |
| OperatingMarginTTM | 5.73 |
| ReturnOnAssetsTTM | 0.238 |
| ReturnOnEquityTTM | 0.402 |
| RevenueTTM | 70741000 |
| GrossProfitTTM | 65992000 |
| DilutedEPSTTM | 0.67 |
| QuarterlyEarningsGrowthYOY | 0.24 |
| QuarterlyRevenueGrowthYOY | -0.89 |
| AnalystTargetPrice | 5.4 |
| AnalystRatingStrongBuy | 0 |
| AnalystRatingBuy | 1 |
| AnalystRatingHold | 4 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 6.21 |
| ForwardPE | 5.24 |
| PriceToSalesRatioTTM | 13.24 |
| PriceToBookRatio | 0.918 |
| EVToRevenue | 5.89 |
| EVToEBITDA | 2.299 |
| Beta | 1.771 |
| 52WeekHigh | 5.72 |
| 52WeekLow | 2.475 |
| 50DayMovingAverage | 5.22 |
| 200DayMovingAverage | 4.697 |
| SharesOutstanding | 225173000 |
| SharesFloat | 180774000 |
| PercentInsiders | 0.095 |
| PercentInstitutions | 10.425 |
| ExDividendDate | None |
| etoro | 1 |
| dateChecked | 2025-12-21 23:42:09 |
| fresh | 1 |